<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">DENV </span>
   <span class="font27">dengue </span>
   <span class="font22">ELISA </span>
   <span class="font18">virus </span>
   <span class="font16">samples </span>
   <span class="font16">serum </span>
   <span class="font15">detection </span>
   <span class="font15">using </span>
   <span class="font14">Dengue </span>
   <span class="font14">capture </span>
   <span class="font13">Platelia </span>
   <span class="font13">serotype-specific </span>
   <span class="font13">clinical </span>
   <span class="font13">positive </span>
   <span class="font13">serotype </span>
   <span class="font12">MAbs </span>
   <span class="font12">viral </span>
   <span class="font12">DENV, </span>
   <span class="font12">serotypes </span>
   <span class="font12">specificity </span>
   <span class="font12">{border-style </span>
   <span class="font12">antibodies </span>
   <span class="font12">infection </span>
   <span class="font12">patients </span>
   <span class="font12">IgM/IgG </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">results </span>
   <span class="font12">serotyping </span>
   <span class="font12">disease </span>
   <span class="font12">infected </span>
   <span class="font12">proteins </span>
   <span class="font12">sensitivity </span>
   <span class="font12">used </span>
   <span class="font12">assay </span>
   <span class="font12">negative </span>
   <span class="font12">severe </span>
   <span class="font11">Trop </span>
   <span class="font11">antibody </span>
   <span class="font11">cells </span>
   <span class="font11">diagnosis </span>
   <span class="font11">infections </span>
   <span class="font11">RT-PCR </span>
   <span class="font11">antigen </span>
   <span class="font11">fever </span>
   <span class="font11">virus-specific </span>
   <span class="font11">MAb-., </span>
   <span class="font11">early </span>
   <span class="font11">ELISA, </span>
   <span class="font11">Kaohsiung </span>
   <span class="font11">MAb </span>
   <span class="font11">MAb-. </span>
   <span class="font11">Vero </span>
   <span class="font11">cases </span>
   <span class="font11">determined </span>
   <span class="font11">diagnostic </span>
   <span class="font11">infection. </span>
   <span class="font11">obtained </span>
   <span class="font11">test </span>
   <span class="font11">Clin </span>
   <span class="font11">ELISA. </span>
   <span class="font11">Med </span>
   <span class="font11">NS. </span>
   <span class="font11">cell </span>
   <span class="font11">methods </span>
   <span class="font11">paired </span>
   <span class="font11">tested </span>
   <span class="font11">(–). </span>
   <span class="font11">CI, </span>
   <span class="font11">Infect </span>
   <span class="font11">RT-PCR, </span>
   <span class="font11">SYBR </span>
   <span class="font11">[/( </span>
   <span class="font11">analysis </span>
   <span class="font11">antigens </span>
   <span class="font11">green </span>
   <span class="font11">hemorrhagic </span>
   <span class="font11">incubated </span>
   <span class="font11">monoclonal </span>
   <span class="font11">performed </span>
   <span class="font11">px; </span>
   <span class="font11">rapid </span>
   <span class="font11">risk </span>
   <span class="font11">serotypes. </span>
   <span class="font11">study </span>
   <span class="font11">{font-family </span>
   <span class="font11"> μl </span>
   <span class="font10">(). </span>
   <span class="font10">Armed </span>
   <span class="font10">City, </span>
   <span class="font10">DENVs </span>
   <span class="font10">Forces </span>
   <span class="font10">General </span>
   <span class="font10">Hyg:–. </span>
   <span class="font10">Taiwan </span>
   <span class="font10">Taiwan, </span>
   <span class="font10">commercial </span>
   <span class="font10">cross-reactivity </span>
   <span class="font10">development </span>
   <span class="font10">different </span>
   <span class="font10">font-size </span>
   <span class="font10">non-dengue </span>
   <span class="font10">one-step </span>
   <span class="font10">second </span>
   <span class="font10">(.–.) </span>
   <span class="font10">(/) </span>
   <span class="font10">(/), </span>
   <span class="font10">. ng/ml, </span>
   <span class="font10">DENV. </span>
   <span class="font10">Dis:e. </span>
   <span class="font10">Dis:–. </span>
   <span class="font10">Immunol:–. </span>
   <span class="font10">KalayanaroojS, </span>
   <span class="font10">NS, </span>
   <span class="font10">Negl </span>
   <span class="font10">RNA </span>
   <span class="font10">TABLE </span>
   <span class="font10">achieved </span>
   <span class="font10">assays </span>
   <span class="font10">differentiate </span>
   <span class="font10">disease. </span>
   <span class="font10">doi:./journal.pntd.. </span>
   <span class="font10">double; </span>
   <span class="font10">enzyme-linked </span>
   <span class="font10">however, </span>
   <span class="font10">identify </span>
   <span class="font10">immunosorbent </span>
   <span class="font10">million </span>
   <span class="font10">multiple </span>
   <span class="font10">plates </span>
   <span class="font10">protein </span>
   <span class="font10">real-time </span>
   <span class="font10">regions </span>
   <span class="font10">supernatant </span>
   <span class="font10">testing </span>
   <span class="font10">tests </span>
   <span class="font10">.GuzmanMG, </span>
   <span class="font10">CI]) </span>
   <span class="font10">Hospital, </span>
   <span class="font10">Institute </span>
   <span class="font10">Microbiol </span>
   <span class="font10">National </span>
   <span class="font10">Preventive </span>
   <span class="font10">Rev </span>
   <span class="font10">Table </span>
   <span class="font10">Zika </span>
   <span class="font10">able </span>
   <span class="font10">accordance </span>
   <span class="font10">accuracy </span>
   <span class="font10">acute </span>
   <span class="font10">anti-NS </span>
   <span class="font10">available </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">develop </span>
   <span class="font10">developed </span>
   <span class="font10">doi:./ajtmh.... </span>
   <span class="font10">flow </span>
   <span class="font10">following </span>
   <span class="font10">follows: </span>
   <span class="font10">generated </span>
   <span class="font10">global </span>
   <span class="font10">high </span>
   <span class="font10">human </span>
   <span class="font10">infections. </span>
   <span class="font10">lateral </span>
   <span class="font10">management </span>
   <span class="font10">medical </span>
   <span class="font10">method </span>
   <span class="font10">onset </span>
   <span class="font10">patient </span>
   <span class="font10">purified </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">stages </span>
   <span class="font10">subsequently </span>
   <span class="font10">total </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.–) </span>
   <span class="font10">(DENV), </span>
   <span class="font10">(Table </span>
   <span class="font10">Aedes </span>
   <span class="font10">BalmasedaA, </span>
   <span class="font10">Branch </span>
   <span class="font10">Centers </span>
   <span class="font10">Clinical </span>
   <span class="font10">Conformational </span>
   <span class="font10">DENVa </span>
   <span class="font10">Disease </span>
   <span class="font10">ELISAs </span>
   <span class="font10">Early </span>
   <span class="font10">IgG </span>
   <span class="font10">Japanese </span>
   <span class="font10">JarmanRG, </span>
   <span class="font10">MAb-.) </span>
   <span class="font10">MAbs. </span>
   <span class="font10">Moreover, </span>
   <span class="font10">NisalakA, </span>
   <span class="font10">No. </span>
   <span class="font10">RT-PCR. </span>
   <span class="font10">ability </span>
   <span class="font10">acute-phase </span>
   <span class="font10">analysis. </span>
   <span class="font10">antibodies) </span>
   <span class="font10">application </span>
   <span class="font10">bold </span>
   <span class="font10">buffer </span>
   <span class="font10">capable </span>
   <span class="font10">caused </span>
   <span class="font10">collected </span>
   <span class="font10">commercially </span>
   <span class="font10">confirmed </span>
   <span class="font10">courier; </span>
   <span class="font10">cross-reactive </span>
   <span class="font10">culture </span>
   <span class="font10">detect </span>
   <span class="font10">em; </span>
   <span class="font10">encephalitis </span>
   <span class="font10">epidemics </span>
   <span class="font10">expensive </span>
   <span class="font10">facilitate </span>
   <span class="font10">fever, </span>
   <span class="font10">form </span>
   <span class="font10">forms </span>
   <span class="font10">illness </span>
   <span class="font10">immunoaffinity-purified </span>
   <span class="font10">involved </span>
   <span class="font10">levels </span>
   <span class="font10">mice </span>
   <span class="font10">no. </span>
   <span class="font10">number </span>
   <span class="font10">outbreaks </span>
   <span class="font10">overall </span>
   <span class="font10">pairing </span>
   <span class="font10">predictive </span>
   <span class="font10">presence </span>
   <span class="font10">pt;} </span>
   <span class="font10">rates </span>
   <span class="font10">resources </span>
   <span class="font10">samples, </span>
   <span class="font10">samples. </span>
   <span class="font10">selected </span>
   <span class="font10">sera </span>
   <span class="font10">serotype-cross-reactive </span>
   <span class="font10">severity </span>
   <span class="font10">soluble </span>
   <span class="font10">step </span>
   <span class="font10">supernatants </span>
   <span class="font10">terms </span>
   <span class="font10">time </span>
   <span class="font10">value </span>
   <span class="font10">various </span>
   <span class="font10"> days </span>
   <span class="font10"> min. </span>
  </p>
 </body>
</html>
